Fang B - Search Results

1

Development of small-molecule inhibitors of Raf.

Wu S, Guo W, Fang B. Wu S, et al. Among authors: fang b. Recent Pat Antiinfect Drug Discov. 2006 Jun;1(2):241-6. doi: 10.2174/157489106777452665. Recent Pat Antiinfect Drug Discov. 2006. PMID: 18221149 Review.

2

Lack of p38 MAP kinase activation in TRAIL-resistant cells is not related to the resistance to TRAIL-mediated cell death.

Zhang L, Zhu H, Davis JJ, Jacob D, Wu S, Teraishi F, Gutierrez A, Wang Y, Fang B. Zhang L, et al. Among authors: fang b. Cancer Biol Ther. 2004 Mar;3(3):296-301. doi: 10.4161/cbt.3.3.696. Epub 2004 Mar 16. Cancer Biol Ther. 2004. PMID: 14749540

3

Induction of apoptosis and down-regulation of Bcl-XL in cancer cells by a novel small molecule, 2[[3-(2,3-dichlorophenoxy)propyl]amino]ethanol.

Wu S, Zhu H, Gu J, Zhang L, Teraishi F, Davis JJ, Jacob DA, Fang B. Wu S, et al. Among authors: fang b. Cancer Res. 2004 Feb 1;64(3):1110-3. doi: 10.1158/0008-5472.can-03-2790. Cancer Res. 2004. PMID: 14871845

4

Induction of S-phase arrest and p21 overexpression by a small molecule 2[[3-(2,3-dichlorophenoxy)propyl] amino]ethanol in correlation with activation of ERK.

Zhu H, Zhang L, Wu S, Teraishi F, Davis JJ, Jacob D, Fang B. Zhu H, et al. Among authors: fang b. Oncogene. 2004 Jun 24;23(29):4984-92. doi: 10.1038/sj.onc.1207645. Oncogene. 2004. PMID: 15122344

5

Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.

Jacob D, Davis J, Zhu H, Zhang L, Teraishi F, Wu S, Marini FC 3rd, Fang B. Jacob D, et al. Among authors: fang b. Clin Cancer Res. 2004 May 15;10(10):3535-41. doi: 10.1158/1078-0432.CCR-03-0512. Clin Cancer Res. 2004. PMID: 15161713

6

Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells.

Zhu H, Guo W, Zhang L, Davis JJ, Teraishi F, Wu S, Cao X, Daniel J, Smythe WR, Fang B. Zhu H, et al. Among authors: fang b. Mol Cancer Ther. 2005 Mar;4(3):451-6. doi: 10.1158/1535-7163.MCT-04-0162. Mol Cancer Ther. 2005. PMID: 15767554

7

Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.

Zhu H, Zhang L, Dong F, Guo W, Wu S, Teraishi F, Davis JJ, Chiao PJ, Fang B. Zhu H, et al. Among authors: fang b. Oncogene. 2005 Jul 21;24(31):4993-9. doi: 10.1038/sj.onc.1208683. Oncogene. 2005. PMID: 15824729 Free PMC article.

8

P-glycoprotein-independent apoptosis induction by a novel synthetic compound, MMPT [5-[(4-methylphenyl)methylene]-2-(phenylamino)-4(5H)-thiazolone].

Teraishi F, Wu S, Sasaki J, Zhang L, Zhu HB, Davis JJ, Fang B. Teraishi F, et al. Among authors: fang b. J Pharmacol Exp Ther. 2005 Jul;314(1):355-62. doi: 10.1124/jpet.105.085654. Epub 2005 Apr 14. J Pharmacol Exp Ther. 2005. PMID: 15831436

9

Enhancing TRAIL-induced apoptosis by Bcl-X(L) siRNA.

Zhu H, Guo W, Zhang L, Davis JJ, Wu S, Teraishi F, Cao X, Smythe WR, Fang B. Zhu H, et al. Among authors: fang b. Cancer Biol Ther. 2005 Apr;4(4):393-7. doi: 10.4161/cbt.4.4.1616. Epub 2005 Apr 21. Cancer Biol Ther. 2005. PMID: 15846108

10

Identification of a novel synthetic thiazolidin compound capable of inducing c-Jun NH2-terminal kinase-dependent apoptosis in human colon cancer cells.

Teraishi F, Wu S, Zhang L, Guo W, Davis JJ, Dong F, Fang B. Teraishi F, et al. Among authors: fang b. Cancer Res. 2005 Jul 15;65(14):6380-7. doi: 10.1158/0008-5472.CAN-05-0575. Cancer Res. 2005. PMID: 16024641 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,347 results

Search Page